Literature DB >> 11002816

Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.

R P Waranis1, K B Sloan.   

Abstract

A series of S6,9-bisacyloxymethyl-6-mercaptopurine (6,9-bis-6-MP) prodrug derivatives was synthesized and characterized. The solubilities of the derivatives in solvents (vehicles), which exhibited a wide range of polarities from water to oleic acid, were measured. The abilities of the prodrugs to deliver 6-mercaptopurine (6-MP) from the vehicles have also been determined, and experimental fluxes and permeability coefficients (Kp) have been calculated for a large number of prodrug: vehicle combinations. Generally the best prodrugs of the series in terms of delivering 6-MP, regardless of the vehicle, were the first two members--the bisacetyl- and the bispropionyloxymethyl-6-mercaptopurine prodrugs. This result has been attributed mainly to the increased water solubility of these two prodrugs compared with that of 6-MP and the other prodrugs, since all of the prodrugs are much more lipid soluble than 6-MP. For three vehicles--isopropyl myristate, propylene glycol, and water--there was a good correlation between log experimental Kp for the delivery of 6-MP by the prodrugs from those vehicles and the theoretical solubility parameters of the prodrugs. The stabilities of the bisacetyl-(2), bisproprionyl-(3), and bisbutyryloxymethyl-6-mercaptopurine (4) derivatives were determined in buffer and in buffer containing enzymes leached from the dermis. Prodrug 2 was more stable than 3 or 4 in the buffer containing the enzymes, while 4 was more stable than 2 or 3 in the plain buffer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 11002816     DOI: 10.1002/jps.2600760803

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Enhanced delivery of zidovudine through rat and human skin via ester prodrugs.

Authors:  T Seki; T Kawaguchi; K Juni
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU.

Authors:  K B Sloan; E F Sherertz; R G McTiernan
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Percutaneous delivery of thalidomide and its N-alkyl analogs.

Authors:  Colleen Goosen; Timothy J Laing; Jeanetta du Plessis; Theunis C Goosen; Guang-Wei Lu; Gordon L Flynn
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

4.  Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.

Authors:  Kenneth B Sloan; Scott Wasdo; Udo Ezike-Mkparu; Thomas Murray; Donna Nickels; Surjit Singh; Thea Shanks; John Tovar; Karen Ulmer; Robert Waranis
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

Review 5.  Prodrug strategies for enhancing the percutaneous absorption of drugs.

Authors:  David D N'Da
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.